Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions
Soriano, V.; Rivas, P.; Nuñez, M.
Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America 47(11): 1486-1489
2008
ISSN/ISBN: 1537-6591 PMID: 18937578 DOI: 10.1086/593105Document Number: 203521
Document emailed within 0-6 h
Related Documents
Anglaret, X.; Scott, C.A.; Walensky, R.P.; Ouattara, E.; Losina, E.; Moh, R.; Becker, J.E.; Uhler, L.; Danel, C.; Messou, E.; Eholié, S.; Freedberg, K.A. 2013: Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? a model-based analysis Antiviral Therapy 18(1): 45-55Bravo, R.; Soriano, V.; García-Samaniego, J.; Gómez-Cano, M.; González-Lahoz, J.; Altisent, C.; Ruiz, I. 1996: Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients Antiviral Therapy 1(3): 194
Ouattara, E.N.; Anglaret, X.; Wong, A.Y.; Chu, J.; Hsu, H.E.; Danel, C.; Eholié, S.; Moh, R.; Gabillard, D.; Walensky, R.P.; Freedberg, K.A. 2012: Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age Aids 26(5): 625-634
Soriano, V.; García-Samaniego, J. 1994: Therapy with interferon in HIV-infected patients with chronic viral hepatitis Revista Clinica Espanola 194(10): 887-889
Macías, J.; Mira, J.é A.; López-Cortés, L.F.; Santos, I.; Girón-González, J.é A.; González-Serrano, M.; Merino, D.; Hernández-Quero, J.é; Rivero, A.; Merchante, N.ás.; Trastoy, M.ón.; Carrillo-Gómez, R.; Arizcorreta-Yarza, A.; Gómez-Mateos, J.ús.; Pineda, J.A. 2006: Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C Antiviral Therapy 11(7): 839-846
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Van Lettow, M.; Åkesson, A.; Martiniuk, A.L.C.; Ramsay, A.; Chan, A.K.; Anderson, S.T.; Harries, A.D.; Corbett, E.; Heyderman, R.S.; Zachariah, R.; Bedell, R.A. 2012: Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi Plos one 7(11): E48856
Peters, P.James.; McNicholl, J.M.; Raengsakulrach, B.; Wasinrapee, P.; Mueanpai, F.; Ratanasuwan, W.; Intalapaporn, P.; Drobeniuc, J.; Ramachandran, S.; Thai, H.; Xia, G-Liang.; Kamili, S.; Khudyakov, Y.; Weidle, P.J.; Teo, C.Gee.; McConnell, M.S. 2013: An evaluation of hepatitis B virus diagnostic methods and responses to antiretroviral therapy among HIV-infected women in Thailand Journal of the International Association of Providers of Aids Care 12(5): 349-353
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Venkatesh, K.K.; Srikrishnan, A.K.; Mayer, K.H.; Kumarasamy, N.; Raminani, S.; Thamburaj, E.; Prasad, L.; Triche, E.W.; Solomon, S.; Safren, S.A. 2010: Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings Aids Patient Care and Stds 24(12): 795-803
Wahl, D.G.; Bounameaux, H.; de Moerloose, P.; Sarasin, F.P. 2000: Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis Archives of Internal Medicine 160(13): 2042-2048
Cooper, C.L.; Mills, E.; Wabwire, B.O.; Ford, N.; Olupot-Olupot, P. 2008: Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 13(3): 302-306
Kundro, M.A.; Viloria, G.A.; Toibaro, J.J.; Losso, M.H. 2017: Antiretroviral therapy and arterial elasticity in HIV-infected patients Medicina 77(5): 365-369
Duval, X.; Trad, S.; Le Moing, V.; Longuet, P.; Leport, C.; Vildé, J.L. 2001: Paradoxical aggravation of tuberculosis after antiretroviral therapy in HIV-infected patients Presse Medicale 30(5): 213-216
Msango, L.; Downs, J.A.; Kalluvya, S.E.; Kidenya, B.R.; Kabangila, R.; Johnson, W.D.; Fitzgerald, D.W.; Peck, R.N. 2011: Renal dysfunction among HIV-infected patients starting antiretroviral therapy Aids 25(11): 1421-1425
Dumortier, J.ér.ôm.; Chiarello, P.; Adham, M.; Delafosse, B.; Chayvialle, J.-A.; Scoazec, J.-Y.; Boillot, O. 2002: Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus Gastroenterologie Clinique et Biologique 26(11): 1061-1062
Kobayashi, T.; Pitisuttithum, P.; Kaewkingwal, J.; Phuphuakrat, A.; Sungkanuparph, S. 2017: Clinical Outcomes of Cryptococcal Meningitis among Hiv-Infected Patients in the Era of Antiretroviral Therapy Southeast Asian Journal of Tropical Medicine and Public Health 48(1): 56-64
Prisicăriu, L.J.; Dorobat, C.M.; Manciuc, C.; Nicolau, I.C. 2011: Metabolic syndrome in HIV-infected patients with favorable response to antiretroviral therapy Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(3): 776-780
Pathipvanich, P.; Rojanawiwat, A.; Ariyoshi, K.; Miura, T.; Pumpradit, W.; Wongchoosie, S.; Yingseree, P.; Warachit, P.; Sawanpanyalert, P. 2004: Mortality analysis of HIV-1 infected patients for prioritizing antiretroviral drug therapy Journal of the Medical Association of Thailand 87(8): 951-954